NEW YORK, Oct. 1 - SurroMed and Callida Genomics will share a $7.6 million grant from the US government to develop a universal high-throughput genotyping system.
The partners said the money, awarded by the National Institute of Standards and Technology's Advanced Technology Program, will help them develop a system that can score more than 100,000 SNPs per patient using a solution-array approach.
Over the next three years, SurroMed, which will receive $4.4 million, will bring to the table its Nanobarcode particle technology. Hyseq subsidiary Callida, which will pocket $3.2 million, will amplify DNA and identify and read SNPs, the companies said. NIST awards require each company to match its portion.
A SurroMed spokesman said the award, in October 2001, was originally slated to go to his company and Applied Biosystems. But ABI balked out, leaving SurroMed scrambling for a new partner. "We identified Callida, and here we are," said the spokesman, August Moretti.
Click here for more information.